Using immunohistochemistry and a cut-off value for positivity defined as at least 5% tumor cells displaying membranous PD-L1 staining, we found PD-L1 expression in 36/80 (45%) of OCSCC, a range similar to published data. The gene discussed is CD274; the disease is neoplasm.